Pharmaceuticals, Biotechnology and Life Sciences
Integrated analysis of systemic inflammation and tumor immune features identifies biologically distinct patient subgroups with differential survival outcomes, outperforming conventional…
Single-dose designed peptide drives structural and functional cardiac repair in a mouse myocardial infarction model SAN FRANCISCO–(BUSINESS WIRE)–Animate Biosciences, a…
Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an…
CyPath® Lung test supported recommendation for surveillance strategy, rather than subjecting elderly patient to an invasive, risky and costly biopsy…
MALVERN, Pa.–(BUSINESS WIRE)–NexEos Bio Vision Health (“NexEos”), a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today…
ImmunityBio partner Accord Healthcare to deploy an 85-person sales force to drive ANKTIVA commercialization across 30 countries Dublin-based subsidiary to…
Growing Clinical Evidence and Physician Adoption Broaden NanoKnife IRE Technology as Treatment Option for Major Solid Tumor Types LATHAM, N.Y.–(BUSINESS…
REDWOOD CITY, Calif.–(BUSINESS WIRE)–#AI–Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry, and AI to discover small molecule therapeutics for age-related…
Proprietary assays demonstrate dual Gq and β-arrestin signaling at 5-HT₂A, pathways linked in peer-reviewed studies to antidepressant and anxiolytic effects…
EMERYVILLE, Calif.–(BUSINESS WIRE)–$OABI #OABI—OmniAb, Inc. (NASDAQ: OABI) will report financial results for the quarter and year ended December 31, 2025,…